NEW YORK, July 19 (Praxis Press) Prophylactic mastectomy is a preventive option for women who wish to reduce their risk of breast cancer but the psychological and social consequences of this procedure ...

Undergoing prophylactic salpingo-oophorectomy (PSO) after previous surgery for BRCA1/BRCA2 breast cancer was associated with a significantly reduced risk of death, according to an Italian ...

WASHINGTON, DC — The survival benefit for contralateral prophylactic mastectomy among women who do not have a BRCA gene mutation is less than 1% at 20 years, a new computer model suggests. "We hope ...

Overall, 71% (n = 684) of eligible women responded to the mailed survey. Of those who responded to the survey, 81% (n = 554) responded to one or both of the open-ended questions. Of the total 1,067 ...

Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As ...

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Women with unilateral breast cancer are increasingly opting for ...

Different Prognostic Value of Cytokeratin-19 mRNA–Positive Circulating Tumor Cells According to Estrogen Receptor and HER2 Status in Early-Stage Breast Cancer We identified 152,755 patients with stage ...

BRCA mutation carriers have a significantly increased risk of contralateral breast cancer, influencing treatment decisions. Prophylactic mastectomy discussions must consider future fertility and ...

Former NBC anchor Jenna Wolfe revealed last month that she tested positive for the BRCA1 mutation. Having the BRCA1 or BRCA2 gene mutation increases a person's risk for ovarian and breast cancer.

My family history of breast cancer emphasized the need to take precautions seriously, especially in consideration of my two children. Olivia Munn’s March 13, 2024 announcement that she was diagnosed ...

"Reassuring" data show more breast cancers with surveillance, but no difference in surviva ...